Detalles de la búsqueda
1.
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.
Br J Cancer
; 120(7): 728-745, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816325
2.
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
Anticancer Res
; 29(5): 1557-62, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19443366
3.
Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations.
Front Oncol
; 8: 425, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370249
4.
A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease.
Clin Breast Cancer
; 7(2): 162-3, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16800977
5.
Clinical experience with sunitinib dose escalation in metastatic renal cell carcinoma.
Asia Pac J Clin Oncol
; 11(3): e1-5, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25560278
6.
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial.
Clin Genitourin Cancer
; 13(1): 50-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25163397
7.
Analysis of molecular cytogenetic changes in metastatic renal cell carcinoma in the setting of everolimus treatment: a pilot project.
Clin Genitourin Cancer
; 12(4): 256-61, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24524969
8.
Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy.
J Cancer Res Clin Oncol
; 139(11): 1917-26, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24037486
9.
Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.
Clin Genitourin Cancer
; 12(4): e143-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24656526
10.
Enduring response to everolimus as third-line therapy in a patient with advanced renal cell carcinoma, including small-bowel metastases: loss of FHIT but normal VHL gene status.
Clin Genitourin Cancer
; 10(3): 202-6, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22440786
11.
Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancer.
Support Cancer Ther
; 4(4): 182-7, 2007 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18632515
Resultados
1 -
11
de 11
1
Próxima >
>>